Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Clinical Insights Inc
mi
from
Glen Burnie, MD
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Clinical Insights Inc
mi
from
Glen Burnie, MD
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Brooklyn Medical Institute
mi
from
Brooklyn, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Brooklyn Medical Institute
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Medical & Behavioral Health Research
mi
from
New York, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Medical & Behavioral Health Research
mi
from
New York, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
The Medical Research Network, LLC
mi
from
New York, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Finger Lakes Clinical Research
mi
from
Rochester, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Midwest Clinical Research Center
mi
from
Dayton, OH
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Oregon Center for Clinical Investigations, Inc
mi
from
Salem, OR
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Oregon Center for Clinical Investigations, Inc
mi
from
Salem, OR
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Carolina Clinical Research Services
mi
from
Columbia, SC
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Carolina Clinical Research Services
mi
from
Columbia, SC
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
FutureSearch Trials of Dallas
mi
from
Dallas, TX
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
FutureSearch Trials of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Bayou City Research, Ltd.
mi
from
Houston, TX
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Bayou City Research, Ltd.
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Radiant Research, Inc.
mi
from
Murray, UT
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Radiant Research, Inc.
mi
from
Murray, UT
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Psychiatric Alliance of The Blue Ridge
mi
from
Charlottesville, VA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Psychiatric Alliance of The Blue Ridge
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
NeuroScience, Inc.
mi
from
Herndon, VA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Northwest Clinical Research Center
mi
from
Bellevue, WA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Summit Research Network LLC
mi
from
Seattle, WA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Summit Research Network LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Northbrooke Research Center
mi
from
Brown Deer, WI
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Northbrooke Research Center
mi
from
Brown Deer, WI
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Dean Foundation
mi
from
Middleton, WI
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Dean Foundation
mi
from
Middleton, WI
Click here to add this to my saved trials
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
A Biobehavioral Intervention for Patients With Gynecologic or Breast Cancer Recurrence
Status: Enrolling
Updated:  10/8/2015
Ohio State University Medical Center
mi
from
Columbus, OH
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
A Biobehavioral Intervention for Patients With Gynecologic or Breast Cancer Recurrence
Status: Enrolling
Updated: 10/8/2015
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Massage To Improve Uterine Artery Blood Flow
Massage to Reduce Intrauterine Artery Resistance, Prematurity and Low Birthweight
Status: Enrolling
Updated:  10/8/2015
University of Miami
mi
from
Miami, FL
Massage To Improve Uterine Artery Blood Flow
Massage to Reduce Intrauterine Artery Resistance, Prematurity and Low Birthweight
Status: Enrolling
Updated: 10/8/2015
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder
A Randomized, Comparator-Controlled, Two-Arm, Parallel Group Study to Determine the Safety and Efficacy of eCBT Mood®, a Handheld, Computerized, Electronic Cognitive Behavioral Therapy Application, in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/12/2015
Compass Research, LLC: North Clinic
mi
from
Leesburg, FL
Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder
A Randomized, Comparator-Controlled, Two-Arm, Parallel Group Study to Determine the Safety and Efficacy of eCBT Mood®, a Handheld, Computerized, Electronic Cognitive Behavioral Therapy Application, in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/12/2015
Compass Research, LLC: North Clinic
mi
from
Leesburg, FL
Click here to add this to my saved trials
Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder
A Randomized, Comparator-Controlled, Two-Arm, Parallel Group Study to Determine the Safety and Efficacy of eCBT Mood®, a Handheld, Computerized, Electronic Cognitive Behavioral Therapy Application, in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/12/2015
Compass Research LLC
mi
from
Orlando, FL
Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder
A Randomized, Comparator-Controlled, Two-Arm, Parallel Group Study to Determine the Safety and Efficacy of eCBT Mood®, a Handheld, Computerized, Electronic Cognitive Behavioral Therapy Application, in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/12/2015
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Greater Phoenix
mi
from
Phoenix, AZ
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Greater Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Colorado Cancer Research Program, Incorporated
mi
from
Denver, CO
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Colorado Cancer Research Program, Incorporated
mi
from
Denver, CO
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
MBCCOP - Hawaii
mi
from
Honolulu, HI
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
MBCCOP - Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Northern New Jersey
mi
from
Hackensack, NJ
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Northern New Jersey
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Marshfield Medical Research and Education Foundation
mi
from
Marshfield, WI
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Marshfield Medical Research and Education Foundation
mi
from
Marshfield, WI
Click here to add this to my saved trials
Treatment of Post-Traumatic Brain Injury (TBI) Depression
Treatment of Post-TBI Depression
Status: Enrolling
Updated:  10/14/2015
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Treatment of Post-Traumatic Brain Injury (TBI) Depression
Treatment of Post-TBI Depression
Status: Enrolling
Updated: 10/14/2015
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program
Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program
Status: Enrolling
Updated:  10/18/2015
Emory Alzheimer's Disease Research Center
mi
from
Atlanta, GA
Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program
Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program
Status: Enrolling
Updated: 10/18/2015
Emory Alzheimer's Disease Research Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005
Status: Enrolling
Updated:  10/20/2015
PRA Health Sciences
mi
from
Marlton, NJ
Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005
Status: Enrolling
Updated: 10/20/2015
PRA Health Sciences
mi
from
Marlton, NJ
Click here to add this to my saved trials
Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
Status: Enrolling
Updated:  10/21/2015
Northwestern University
mi
from
Chicago, IL
Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
Status: Enrolling
Updated: 10/21/2015
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Project BEST: Buprenorphine Entry Into Substance Abuse Treatment
Project BEST: Buprenorphine Entry Into Substance Abuse Treatment
Status: Enrolling
Updated:  10/21/2015
Yale University
mi
from
New Haven, CT
Project BEST: Buprenorphine Entry Into Substance Abuse Treatment
Project BEST: Buprenorphine Entry Into Substance Abuse Treatment
Status: Enrolling
Updated: 10/21/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
University of California-Davis, Imaging Research Center
mi
from
Sacramento, CA
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
University of California-Davis, Imaging Research Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
Portland Identification and Early Referral Program
mi
from
Portland, ME
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
Portland Identification and Early Referral Program
mi
from
Portland, ME
Click here to add this to my saved trials